These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 36100788)

  • 1. Focusing the pivotal role of nanotechnology in Huntington's disease: an insight into the recent advancements.
    Singh S; Hema ; Sharma N; Sachdeva M; Behl T; Zahoor I; Fuloria NK; Sekar M; Fuloria S; Subramaniyan V; Alsubayiel AM; Dailah HG; Naved T; Bhatia S; Al-Harrasi A; Aleya L
    Environ Sci Pollut Res Int; 2022 Oct; 29(49):73809-73827. PubMed ID: 36100788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
    Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
    Elife; 2021 Apr; 10():. PubMed ID: 33871358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards a transgenic model of Huntington's disease in a non-human primate.
    Yang SH; Cheng PH; Banta H; Piotrowska-Nitsche K; Yang JJ; Cheng EC; Snyder B; Larkin K; Liu J; Orkin J; Fang ZH; Smith Y; Bachevalier J; Zola SM; Li SH; Li XJ; Chan AW
    Nature; 2008 Jun; 453(7197):921-4. PubMed ID: 18488016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple clinical features of Huntington's disease correlate with mutant HTT gene CAG repeat lengths and neurodegeneration.
    Podvin S; Reardon HT; Yin K; Mosier C; Hook V
    J Neurol; 2019 Mar; 266(3):551-564. PubMed ID: 29956026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Features of Huntington's Disease.
    Ghosh R; Tabrizi SJ
    Adv Exp Med Biol; 2018; 1049():1-28. PubMed ID: 29427096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Huntington's Disease: Complex Pathogenesis and Therapeutic Strategies.
    Tong H; Yang T; Xu S; Li X; Liu L; Zhou G; Yang S; Yin S; Li XJ; Li S
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.
    Cho IK; Yang B; Forest C; Qian L; Chan AWS
    PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Huntington's disease: intracellular signaling pathways and neuronal death].
    Humbert S; Saudou F
    J Soc Biol; 2005; 199(3):247-51. PubMed ID: 16471265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetics of Huntington's Disease.
    Bassi S; Tripathi T; Monziani A; Di Leva F; Biagioli M
    Adv Exp Med Biol; 2017; 978():277-299. PubMed ID: 28523552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirtuins as Modifiers of Huntington's Disease (HD) Pathology.
    Neo SH; Tang BL
    Prog Mol Biol Transl Sci; 2018; 154():105-145. PubMed ID: 29413175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zebrafish an experimental model of Huntington's disease: molecular aspects, therapeutic targets and current challenges.
    Kumar V; Singh C; Singh A
    Mol Biol Rep; 2021 Dec; 48(12):8181-8194. PubMed ID: 34665402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
    Liu W; Chaurette J; Pfister EL; Kennington LA; Chase KO; Bullock J; Vonsattel JP; Faull RL; Macdonald D; DiFiglia M; Zamore PD; Aronin N
    J Huntingtons Dis; 2013; 2(4):491-500. PubMed ID: 25062733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
    Reddy PH; Charles V; Williams M; Miller G; Whetsell WO; Tagle DA
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1035-45. PubMed ID: 10434303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reviewing Biochemical Implications of Normal and Mutated Huntingtin in Huntington's Disease.
    Tellone E; Galtieri A; Ficarra S
    Curr Med Chem; 2020; 27(31):5137-5158. PubMed ID: 31223078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From Pathogenesis to Therapeutics: A Review of 150 Years of Huntington's Disease Research.
    Jiang A; Handley RR; Lehnert K; Snell RG
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular biology of Huntington's disease.
    Ho LW; Carmichael J; Swartz J; Wyttenbach A; Rankin J; Rubinsztein DC
    Psychol Med; 2001 Jan; 31(1):3-14. PubMed ID: 11200958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioenergetics in Huntington's disease.
    Grünewald T; Beal MF
    Ann N Y Acad Sci; 1999; 893():203-13. PubMed ID: 10672239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective neuronal degeneration in Huntington's disease.
    Cowan CM; Raymond LA
    Curr Top Dev Biol; 2006; 75():25-71. PubMed ID: 16984809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards a comprehensive understanding of the contributions of mitochondrial dysfunction and oxidative stress in the pathogenesis and pathophysiology of Huntington's disease.
    Tobore TO
    J Neurosci Res; 2019 Nov; 97(11):1455-1468. PubMed ID: 31304621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive perspective of Huntington's disease and mitochondrial dysfunction.
    Dai Y; Wang H; Lian A; Li J; Zhao G; Hu S; Li B
    Mitochondrion; 2023 May; 70():8-19. PubMed ID: 36906250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.